Inmed Pharmaceuticals Inc. · NASDAQ:INM

Vivo Opportunity, LLC bought 6,551 Inmed Pharmaceuticals Inc. shares (Form 4)

Traded Jun 30 to Jul 2, 2026 · Filed Jul 2, 2026

From Jun 30 to Jul 2, 2026, Vivo Opportunity, LLC (10% owner) bought 6,551 Inmed Pharmaceuticals Inc. shares at an average US$1.55 for US$10,148, leaving 73,135 shares. Filed Jul 2, 2026 (Form 4).

Bought
6,551 shares
Price
US$1.55 average (US$1.54 to US$1.55)
Value
US$10,148
Holding after
73,135 shares (held indirectly)
Trading plan
No
Role
10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 30, 2026Common SharesBuy545US$1.54718,989Indirect
Jun 30, 2026Common SharesBuy55US$1.5472,590Indirect
Jul 1, 2026Common SharesBuy3,946US$1.55722,935Indirect
Jul 1, 2026Common SharesBuy398US$1.5572,988Indirect
Jul 2, 2026Common SharesBuy1,460US$1.55724,395Indirect
Jul 2, 2026Common SharesBuy147US$1.5573,135Indirect

Source

View original at SEC

Related